While antiretroviral therapy has transformed HIV into a manageable condition, the search for a preventive vaccine continues. Dr. Sehulong Robert […]
Exploring a Novel HIV Vaccine Strategy: Dr. Moraba’s Role in the VIR-1388 Trial Read Post »
Building on the fight against TB, Dr. Sehulong Robert Moraba also contributed to the development of MTBVAC, a live-attenuated vaccine derived
Evaluating a Next-Generation TB Vaccine: Dr. Moraba in MTBVAC Phase 2a Trial Read Post »
The standard treatment for drug-sensitive TB is lengthy and complex. Dr. Sehulong Robert Moraba participated in research aimed at changing
Shortening and Simplifying TB Treatment: Dr. Moraba’s Work on the NC-009 Trial Read Post »
The burden of RSV is highest in the very young. Dr. Sehulong Robert Moraba participated in a major international effort
The PEARL Trial: Dr. Moraba Helps Evaluate an RSV Vaccine for the Youngest Children Read Post »
Following his work on the mRNA flu vaccine, Dr. Sehulong Robert Moraba also contributed to Moderna’s pipeline for maternal health.
Protecting the Most Vulnerable: Dr. Moraba in Moderna’s Maternal RSV Vaccine Trial Read Post »
As the COVID-19 pandemic evolved, so did the search for next-generation vaccines. Dr. Sehulong Robert Moraba contributed to this effort
Beyond the Pandemic: Dr. Moraba in Early Trial for Next-Gen COVID-19 Vaccines Read Post »
Adolescent girls and young women in sub-Saharan Africa remain disproportionately affected by HIV. Dr. Sehulong Robert Moraba worked to expand
Expanding HIV Prevention Options for Young Women: Dr. Moraba in F/TAF PrEP Trial Read Post »
Before a large efficacy trial can launch, critical groundwork must be laid. Dr. Sehulong Robert Moraba served as a Sub-Investigator for a
With rising antibiotic resistance, gonorrhoea is becoming harder to treat. Dr. Sehulong Robert Moraba contributed to the fight against this
The success of mRNA technology during the COVID-19 pandemic opened new avenues for other vaccines. Dr. Sehulong Robert Moraba took
Respiratory Syncytial Virus (RSV) is a leading cause of severe respiratory illness in infants. Pregnant women living with HIV and
Tuberculosis remains one of the world’s deadliest infectious diseases. The M72/AS01E vaccine candidate has emerged as one of the most promising new
A Historic Step Forward: Dr. Moraba Contributes to Phase 3 Trial of Promising TB Vaccine Read Post »
Beyond any single study, Dr. Sehulong Robert Moraba’s most significant accomplishment may be his foundational role as Clinical Trials Director and
The Foundation of Discovery: Dr. Moraba’s Directorship in Clinical Trial Operations Read Post »
Adherence to daily pills is a major challenge for HIV prevention. Dr. Sehulong Robert Moraba was at the forefront of
